Eksin, M. A. Et Al. 2022. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review. Immunotherapy , vol.14, no.6 , 401-408.

Eksin, M. A., Erden, A., Güven, S. C., Armagan, B., Ozdemir, B., Karakas, O., ... Omma, A.(2022). Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review. Immunotherapy , vol.14, no.6, 401-408.

Eksin, Mehmet Et Al. "Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review," Immunotherapy , vol.14, no.6, 401-408, 2022

Eksin, Mehmet A. Et Al. "Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review." Immunotherapy , vol.14, no.6, pp.401-408, 2022

Eksin, M. A. Et Al. (2022) . "Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review." Immunotherapy , vol.14, no.6, pp.401-408.

@article{article, author={Mehmet Akif Eksin Et Al. }, title={Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review}, journal={Immunotherapy}, year=2022, pages={401-408} }